Herzich Paul — SEC Form 4 filings
SEC reporting owner CIK 1954991. 10 Form 4 filings on record with FilingPulse; latest filed 2026-04-21.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-04-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 48,937 shares, $300,272 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 26,250 shares @ $6.44 ($168,969) in Solid Biosciences Inc., filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | Chief Technology Officer | 10 | — | 6 legs · 48,937 sh · $300,272 | 20 |
Form 4 filings — Herzich Paul
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-21 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 54,925 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 7,187 · Sale (S): 3,616 @ $5.82 · Option exercise (M): 7,187 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 10,905 @ $6.44 | EDGAR |
| 2026-02-02 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 54,925 · Option exercise (M): 24,675 · Sale (S): 26,250 @ $6.44 · Option exercise (M): 54,925 (derivative) @ $0 · Grant/award (A): 170,000 (derivative) @ $0 · Grant/award (A): 85,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-04 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 7,239 · Sale (S): 2,701 @ $5.11 · Option exercise (M): 7,239 (derivative) @ $0 | EDGAR |
| 2025-08-18 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 7,187 · Sale (S): 2,688 @ $3.96 · Option exercise (M): 7,187 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 98,700 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 7,239 · Sale (S): 2,777 @ $5.60 · Option exercise (M): 7,239 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 57,500 (derivative) @ $0 · Grant/award (A): 28,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1954991 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →